Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRTSP
3426
DELISTED
Virtus Investment Partners, Inc. 7.25% Series D Mandatory Convertible Preferred Stock
VRTSP
| $1.19M | ﹤0.01% |
11,936
-25,000
| -68% | -$2.67M |
|
3427
PUT
Interactive Brokers
IBKR
$41.4B
| $1.18M | ﹤0.01% |
85,600
+72,800
| +569% | +$1.1M |
|
3428
MiMedx Group
MDXG
$624M
| $1.18M | ﹤0.01% |
191,594
+77,407
| +68% | +$350K |
|
|
NBLX
3429
DELISTED
Noble Midstream Partners LP
NBLX
| $1.18M | ﹤0.01% |
33,420
+12,260
| +58% | +$571K |
|
|
XENT
3430
DELISTED
Intersect ENT, Inc
XENT
| $1.18M | ﹤0.01% |
41,010
+36,997
| +922% | +$1.11M |
|
|
FARO
3431
DELISTED
Faro Technologies
FARO
| $1.18M | ﹤0.01% |
18,289
+11,908
| +187% | +$759K |
|
3432
JELD-WEN Holding
JELD
$170M
| $1.18M | ﹤0.01% |
47,749
-10,393
| -18% | -$277K |
|
|
NVTA
3433
DELISTED
Invitae Corporation
NVTA
| $1.18M | ﹤0.01% |
70,306
+35,779
| +104% | +$407K |
|
3434
PUT
British American Tobacco
BTI
$124B
| $1.17M | ﹤0.01% |
25,148
+3,900
| +18% | +$198K |
|
3435
PUT
iShares Core S&P 500 ETF
IVV
$910B
| $1.17M | ﹤0.01% |
4,000
-3,600
| -47% | -$1.03M |
|
|
JNPR
3436
CALL
DELISTED
Juniper Networks
JNPR
| $1.17M | ﹤0.01% |
39,000
-252,600
| -87% | -$7.06M |
|
3437
Customers Bancorp
CUBI
$2.8B
| $1.17M | ﹤0.01% |
49,604
+20,716
| +72% | +$537K |
|
3438
Perdoceo Education
PRDO
$1.96B
| $1.17M | ﹤0.01% |
78,183
+52,186
| +201% | +$860K |
|
|
TRCO
3439
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $1.17M | ﹤0.01% |
30,362
-33,225
| -52% | -$1.2M |
|
3440
Ring Energy
REI
$349M
| $1.17M | ﹤0.01% |
117,607
+45,809
| +64% | +$549K |
|
3441
Bankunited
BKU
$3.41B
| $1.16M | ﹤0.01% |
32,805
-11,799
| -26% | -$465K |
|
3442
CALL
Cemex
CX
$16B
| $1.16M | ﹤0.01% |
165,000
-39,600
| -19% | -$278K |
|
|
PGNX
3443
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.16M | ﹤0.01% |
184,335
-10,171
| -5% | -$78.1K |
|
|
TARO
3444
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.15M | ﹤0.01% |
11,733
+4,033
| +52% | +$436K |
|
|
CLVS
3445
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.15M | ﹤0.01% |
39,300
-37,300
| -49% | -$1.44M |
|
|
BBBY
3446
Bed Bath & Beyond
BBBY
$423M
| $1.15M | ﹤0.01% |
55,407
+9,245
| +20% | +$228K |
|
3447
Casella Waste Systems
CWST
$5.79B
| $1.15M | ﹤0.01% |
37,043
+21,715
| +142% | +$618K |
|
3448
Standard Motor Products
SMP
$877M
| $1.15M | ﹤0.01% |
23,294
+15,014
| +181% | +$745K |
|
|
DPLO
3449
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.15M | ﹤0.01% |
59,133
-21,090
| -26% | -$449K |
|
3450
AMC Entertainment Holdings
AMC
$2.35B
| $1.15M | ﹤0.01% |
5,597
-1,248
| -18% | -$226K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.